PRRT2 and hepatocellular carcinoma: Previous reports have indicated that daphnoretin is a protein kinase C (PKC) activator that possesses antiviral activity by functioning on the PKC pathway to suppress hepatitis B virus expression in human hepatoma cells [20,21].